Target: Human leukocyte antigen (HLA) class I molecules (HLA-A, B, C) .
Applications:
Flow cytometry
Immunoprecipitation
Immunohistochemistry (frozen tissues)
Key Features:
Target: Conserved S2-helix region in beta-coronavirus spikes (e.g., SARS-CoV-2, MERS-CoV) .
Neutralization Mechanism:
Cross-Reactivity: Neutralizes SARS-CoV-2 variants, SARS-CoV, and bat/pangolin coronaviruses .
Unique Properties:
While WOX6-specific data are unavailable, general antibody validation protocols from the search results include:
Verify the spelling or nomenclature of "WOX6" with the originating laboratory or database.
Explore antibodies targeting similar epitopes (e.g., conserved viral regions, HLA class I) using the methodologies described in .
Consult repositories like the Developmental Studies Hybridoma Bank (DSHB) or Antibody Registry for unpublished datasets .
WOX6 is a homeobox domain-containing protein expressed in various plant species and belongs to the WUSCHEL-related homeobox (WOX) family of transcription factors. These proteins play crucial roles in plant development, particularly in meristem maintenance, organ development, and embryogenesis. WOX6 specifically contributes to reproductive development and leaf morphogenesis in several plant species. Studying WOX6 provides insights into fundamental developmental processes in plants, making WOX6 antibody an essential tool for developmental biology research .
WOX6 antibody (particularly product PHY4370S) has demonstrated cross-reactivity with multiple agriculturally important species including Oryza sativa (rice), Zea mays (corn), Triticum aestivum (wheat), Hordeum vulgare subsp. vulgare (barley), Sorghum bicolor (sorghum), Setaria viridis (green foxtail), and Panicum virgatum (switchgrass). This wide cross-reactivity makes it particularly valuable for comparative studies across cereal crops and model plant systems .
WOX6 antibody is typically provided in lyophilized form and requires specific storage conditions to maintain its activity. It should be stored in a manual defrost freezer to avoid degradation. When shipped at 4°C, it should be immediately transferred to the recommended storage temperature upon receipt. Additionally, repeated freeze-thaw cycles should be avoided as they can compromise antibody activity and specificity .
The WOX6 antibody is raised against the immunogen Os03g0325600 (Q10M28), which corresponds to the WOX6 protein in rice. The antibody recognizes epitopes within the homeobox domain, a highly conserved DNA-binding motif in WOX family proteins. This conservation explains the cross-reactivity across multiple plant species, while the specificity for WOX6 is determined by unique sequence elements outside the highly conserved regions .
WOX6 antibody can be utilized in multiple experimental approaches including:
Immunohistochemistry (IHC) for tissue localization
Immunocytochemistry (ICC) for cellular localization
Western blotting for protein expression analysis
Chromatin immunoprecipitation (ChIP) for DNA-binding studies
Immunoprecipitation (IP) for protein-protein interaction studies
Similar to other research antibodies, experimental conditions require optimization for each application and plant species. When designing experiments, researchers should consider protocols similar to those established for other plant transcription factor antibodies, with appropriate modifications for the specific characteristics of WOX6 .
Optimal dilutions of WOX6 antibody should be determined empirically for each experimental system and application. For immunohistochemistry applications, a dilution series (e.g., 1:500, 1:1000, 1:2000) should be tested. When transitioning between plant species, particularly those with greater evolutionary distance, additional optimization may be necessary. Documentation of signal-to-noise ratios across different dilutions is essential for determining optimal conditions. For Western blot applications, preliminary experiments with positive controls expressing known levels of WOX6 protein are recommended to establish sensitivity thresholds .
When working with WOX6 antibody, several controls are essential:
| Control Type | Purpose | Implementation |
|---|---|---|
| Positive control | Validates antibody activity | Use tissues known to express WOX6 (e.g., developing ovules, leaf primordia) |
| Negative control | Assesses non-specific binding | Use tissues with minimal WOX6 expression or wox6 mutant tissues |
| Secondary antibody control | Evaluates secondary antibody specificity | Omit primary antibody but include secondary antibody |
| Isotype control | Measures background binding | Use non-specific antibody of same isotype |
| Blocking peptide | Confirms epitope specificity | Pre-incubate antibody with immunizing peptide |
These controls help distinguish specific signals from background and validate experimental findings, particularly when studying novel expression patterns or previously uncharacterized tissues .
Antibody specificity validation is crucial, especially when studying WOX6 in less characterized plant species. A multi-layered approach is recommended:
Conduct Western blot analysis to confirm single band of appropriate molecular weight
Perform immunoprecipitation followed by mass spectrometry to identify captured proteins
Compare antibody staining patterns with mRNA expression data from in situ hybridization
Test antibody in wox6 knockout/knockdown plants as negative controls
Use epitope competition assays with the immunizing peptide
Consider orthogonal methods such as GFP-tagged WOX6 protein localization
This comprehensive validation approach provides confidence in antibody specificity and experimental results .
Recent advances in computational modeling of antibody-antigen interactions can be applied to enhance WOX6 antibody research. Similar to approaches used for other antibodies, biophysics-informed models can identify different binding modes associated with specific ligands, allowing for prediction and generation of variants with customized specificity profiles. This approach could be particularly valuable for designing WOX6 antibodies with either enhanced specificity for particular WOX family members or broader cross-reactivity across multiple WOX proteins, depending on research needs. The methodology involves training models on experimentally selected antibodies and predicting outcomes for new combinations of ligands .
Integration of WOX6 antibody-based detection with single-cell technologies offers powerful new insights into plant development. Consider adapting approaches like those used in plasma B cell research, where nanovials captured individual cells and their secretions. For WOX6 research, similar techniques could isolate individual plant cells expressing WOX6 from developing tissues. Single-cell RNA sequencing could then be combined with WOX6 protein expression data to correlate transcriptional networks with protein abundance at the single-cell level, revealing cell-specific functions of WOX6 during development .
WOX family proteins share high sequence homology, particularly in the homeobox domain, potentially causing cross-reactivity challenges. To address this:
Epitope mapping can identify unique regions for generating more specific antibodies
Competitive binding assays with recombinant WOX proteins can quantify cross-reactivity
Biophysics-informed computational design can optimize antibody specificity
Sequential immunoprecipitation can distinguish between related proteins
Complementary genetic approaches using CRISPR-modified plants can validate findings
These approaches help ensure that observed signals are truly attributable to WOX6 rather than related family members .
Topological data analysis (TDA) represents an advanced computational approach that could be adapted to WOX6 expression studies. Similar to its application in antibody dynamics analysis for COVID-19 patients, TDA could identify patterns in WOX6 expression across developmental stages or environmental conditions. This method examines the "shape" of data, potentially revealing previously unrecognized relationships between WOX6 expression and phenotypic outcomes. Implementing TDA requires:
Collection of quantitative WOX6 expression data across multiple conditions
Application of dimensionality reduction techniques
Construction of topological networks representing expression patterns
Identification of critical developmental transitions based on network structure
This advanced analytical approach could reveal subtle patterns in WOX6 function that traditional analyses might miss .
Several factors can contribute to weak or inconsistent signals with WOX6 antibody:
| Issue | Potential Cause | Solution |
|---|---|---|
| Weak signal | Insufficient antigen | Optimize tissue fixation; increase antibody concentration |
| No signal | Epitope destruction | Test alternative fixation methods; use antigen retrieval |
| Background staining | Non-specific binding | Increase blocking time/concentration; optimize antibody dilution |
| Variable results | Sample heterogeneity | Standardize tissue collection; increase biological replicates |
| Signal in unexpected tissues | Cross-reactivity | Validate with secondary methods; use competitive blocking |
Systematic troubleshooting based on this framework can address most common issues encountered with WOX6 antibody .
Discrepancies between protein and transcript levels are not uncommon in biological systems due to post-transcriptional regulation. When WOX6 antibody detection contradicts mRNA expression data:
Verify antibody specificity using methods outlined in question 2.4
Consider temporal dynamics (protein may persist after mRNA degradation)
Investigate post-transcriptional regulation mechanisms specific to WOX6
Examine protein stability and turnover rates in different tissues
Employ ribosome profiling to assess translation efficiency
Use reporter fusions to monitor real-time protein dynamics
Integration of multiple methodologies provides a more comprehensive understanding of WOX6 regulation than either approach alone .
Quantitative analysis of WOX6 expression requires standardized approaches:
For Western blot quantification:
Use internal loading controls specific for plant tissues
Establish standard curves with recombinant WOX6 protein
Employ digital image analysis with appropriate background correction
For immunohistochemistry quantification:
Utilize automated image analysis with defined thresholds
Include calibration standards in each experiment
Normalize signal intensity to cell number or tissue area
For high-throughput approaches:
Consider multiplexed antibody arrays for comparative analysis
Use flow cytometry for cellular-level quantification in protoplasts
These approaches enable robust comparison of WOX6 expression across different experimental conditions, genetic backgrounds, or developmental stages .
CRISPR technology offers powerful complementary approaches to WOX6 antibody studies. Researchers can:
Generate epitope-tagged WOX6 variants for enhanced detection sensitivity
Create precise wox6 mutants as negative controls for antibody validation
Introduce domain-specific mutations to map functional regions recognized by the antibody
Develop conditional WOX6 expression systems to study temporal requirements
Create reporter lines with fluorescent proteins under native WOX6 regulatory elements
These genetic tools, when combined with antibody-based approaches, provide unprecedented insights into WOX6 function and regulation in plant development .
Several innovative applications for WOX6 antibody are emerging:
Chromatin immunoprecipitation sequencing (ChIP-seq) to identify WOX6 target genes
Proximity labeling methods to identify WOX6 protein interaction networks
Live-cell imaging using fluorescently-labeled antibody fragments
Super-resolution microscopy for precise subcellular localization
Antibody-based protein degradation approaches for temporal control of WOX6 function
Cross-species comparative studies to elucidate evolutionary conservation of WOX6 function
These emerging applications expand the utility of WOX6 antibody beyond traditional detection methods into functional studies that address fundamental questions in plant developmental biology .